Isolate No | Antimicrobial resistance pattern | Biofilm formation | Virulence genes relative expressionb | Accession No. | ||||||
---|---|---|---|---|---|---|---|---|---|---|
OD570a | Degree | hyl | cylE | sip | scpB | rip | lmb | |||
1 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP | 0.498 | Weak | 1.16 | 1.09 | – | 1.20 | – | 1.50 | MW133069 |
2 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC | 0.492 | Weak | 1.15 | 1.12 | – | 1.21 | – | 1.53 | MW133070 |
3 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC | 1.121 | Strong | 1.10 | 1.04 | – | 1.14 | – | 1.42 | MW133071 |
4 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT, AMC | 0.514 | Weak | 1.14 | 1.07 | – | 1.16 | – | 1.43 | MW133072 |
5 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT | 0.508 | Weak | 1.13 | 1.04 | – | 1.15 | – | 1.45 | MW133073 |
6 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC | 0.484 | Weak | 1.16 | 0.97 | – | 1.15 | – | 1.46 | MW133074 |
7 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC | 0.812 | Moderate | 1.13 | 1.05 | – | 1.23 | – | 1.47 | MW133075 |
8 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP | 0.494 | Weak | 1.37 | 1.05 | – | 1.44 | – | 1.81 | MW133076 |
9 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC | 0.492 | Weak | 1.14 | 1.13 | – | 1.22 | – | 1.53 | MW133077 |
10 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, AMC | 1.118 | Strong | 1.11 | 1.04 | – | 1.04 | – | 1.43 | MW133078 |
11 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT, AMC | 0.434 | Weak | 1.14 | 1.07 | – | 1.14 | – | 1.43 | MW133079 |
12 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E, CFP, SXT | 0.528 | Weak | 1.13 | 1.04 | – | 1.16 | – | 1.46 | MW133080 |
13 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E | 0.470 | Weak | 1.14 | 1.03 | – | 1.06 | – | 1.45 | MW133081 |
14 | P, AX, CX, CRO, CL, FEP, S, DA, TE, E | 0.820 | Moderate | 1.14 | 1.06 | – | 1.15 | – | 1.48 | MW133082 |